Raphael Pharmaceutical (RAPH) Notes Payables (2020 - 2025)
Raphael Pharmaceutical (RAPH) reported Notes Payables of $946000.0 for Q4 2025, up 2207.32% on a YoY basis from $41000.0 in Q4 2024, and up 25.3% sequentially from $755000.0 in Q3 2025.
Raphael Pharmaceutical (RAPH) Notes Payables (2020 - 2025) Analysis & Trends
Raphael Pharmaceutical (RAPH) has 5 years of Notes Payables data on file, last reported at $946000.0 in Q4 2025.
- For the quarter ending Q4 2025, Notes Payables rose 2207.32% year-over-year to $946000.0; the trailing twelve-month figure through Dec 2025 stood at $946000.0 (up 2207.32% YoY), and the FY2025 full-year result was $946000.0, up 2207.32% from the prior year.
- Notes Payables rose to $946000.0 in Q4 2025, from $755000.0 in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $946000.0 in Q4 2025 to a low of $3000.0 in Q4 2022.
- A 4-year average of $178083.3 and a median of $40500.0 in 2023 frame the typical range for Notes Payables.
- Across the five-year window, Notes Payables slumped 33.33% in 2024 and jumped 2207.32% in 2025, its largest moves.
- Tracing RAPH's Notes Payables over 4 years: stood at $3000.0 in 2022, then jumped by 1166.67% to $38000.0 in 2023, then advanced by 7.89% to $41000.0 in 2024, then jumped by 2207.32% to $946000.0 in 2025.
- Business Quant data shows RAPH's Notes Payables at $946000.0 in Q4 2025, $755000.0 in Q3 2025, and $41000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Raphael Pharmaceutical | 27.37 Mn | 27.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 946,000.00 |
| Sep 30, 2025 | 755,000.00 |
| Jun 30, 2025 | 41,000.00 |
| Mar 31, 2025 | 41,000.00 |
| Dec 31, 2024 | 41,000.00 |
| Sep 30, 2024 | 130,000.00 |
| Jun 30, 2024 | 26,000.00 |
| Mar 31, 2024 | 37,000.00 |
| Dec 31, 2023 | 38,000.00 |
| Sep 30, 2023 | 40,000.00 |
| Jun 30, 2023 | 39,000.00 |
| Dec 31, 2022 | 3,000.00 |
| Dec 31, 2020 | 357,000.00 |